Nuo Therapeutics, Inc. (AURX)

EBITDA

-$1.56M

TTM · Period ending: · USD

AURX logo

AURX EBITDA

Latest reported-$1.56M
AURX TTM EBITDA (-$33.38M → -$1.56M)
High-resolution chart · PNG

AURX ebitda history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Nuo Therapeutics, Inc. EBITDA — Trailing twelve months (TTM) (USD)
Period endingEBITDA (USD)
-1,559,437
-2,049,797
-2,359,654
-2,423,579
-2,484,197
-2,394,969
-2,361,566
-2,385,820
-2,593,161
-2,916,483
-3,064,106
-3,373,614
-3,497,391
-3,554,808
-3,095,554
-2,160,939
-1,272,914
-370,091
0
-144,082
-127,871
-38,313
-67,813
-280,737
-883,576
-790,449
-1,367,570
-1,574,318
-1,629,332
-9,564,311
-10,040,685
-13,119,777
-13,852,961
-8,095,296
-8,618,705
-6,664,495
-9,745,712
-11,236,776
-12,961,306
-15,532,958
-14,278,691
-15,212,167
-16,335,957
-16,993,433
-18,224,144
-17,408,508
-17,309,041
-16,765,151
-15,996,768
-21,517,682
-20,358,819
-22,873,588
-23,436,704
-12,964,151
-10,643,383
-4,992,718
-2,248,225
-4,929,627
-5,168,025
-5,356,172
-4,934,151
-4,685,606
-4,129,938
-3,585,516
-3,416,058
-3,468,856
-3,771,202
-4,144,104
-4,180,082
-4,160,256
-5,879,552
-5,292,646
-5,228,289
-5,066,956
-3,199,113
-3,447,134
-3,334,207
-3,355,141
-3,863,016
-4,564,271
-5,240,207
-5,616,150
-5,683,414
-5,329,021
-4,872,150
-4,874,210
-4,579,969
-4,424,097
-4,131,704
-3,569,544
-3,433,383
-2,864,226
-2,627,681
-2,203,361
-1,465,854
-3,051,076
-4,775,809
-22,871,391
-27,847,107
-29,062,532
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.